From the facts described above, in particular the induction of cell proliferation and antiapoptotic action, at first glance, it might seem that NKA may not be a suitable target for tumor therapy, in which the antiproliferative effects and proapoptotic action are highly desired. This evidence concerns the gene TAC1 and neoplasm.